Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Filings indexed 2,823 across all filing types
Latest filing 2016-09-12 Major Shareholding Noti…
Country DK Denmark
Listing CO GMAB

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major Shareholder Announcement" and details a change in indirect ownership by a major shareholder (FMR LLC/Fidelity Management and Research) falling below a specific threshold (4.94%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant share ownership levels crossing thresholds. The filing code for this is MRQ.
2016-09-12 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is a 'Storaktionærmeddelelse' (Major Shareholder Announcement) from Genmab A/S. It explicitly states that FMR LLC has reduced its ownership stake below a certain threshold (4.94%), which is a standard regulatory disclosure requirement for major shareholding notifications. This fits the definition of a Major Shareholding Notification (MRQ).
2016-09-12 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 92% confidence The document is a Danish “Storaktionærmeddelelse” under the Securities Act (§29) notifying a change in an indirect major shareholding (FMR LLC reducing to 4.94%). This is a classic “Major Shareholding Notification” (crossing reporting thresholds). There is no financial report content, only shareholding disclosure. Hence, Code MRQ.
2016-09-12 Danish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 98% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and specifically references a "Storaktionærmeddelelse" (Major Shareholder Announcement) concerning FMR LLC crossing a threshold (5.04% ownership) as required by Danish securities law (Værdipapirlovens paragraf 29). This type of filing reports changes in significant share ownership levels. This directly matches the definition for Major Shareholding Notification (MRQ). The document is short and is an announcement, not a comprehensive report like a 10-K or IR.
2016-09-08 Danish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document is titled "Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states under Danish securities law (Værdipapirlovens paragraf 29) that an indirect ownership stake by FMR LLC (Fidelity Management and Research) in Genmab A/S has crossed a threshold, now totaling 5.04% of the share capital. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant share ownership levels crossing thresholds. The filing code for this is MRQ.
2016-09-08 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a change in major shareholding (crossing the 5% threshold) by FMR LLC in Genmab A/S. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2016-09-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.